Summary:
- The article explores the transformative potential of metagenomic next-generation sequencing (mNGS) in clinical diagnostics, allowing for the simultaneous identification of all pathogens in a sample without requiring prior knowledge of the specific organism.
- It highlights how this technology addresses the limitations of traditional culture-based methods, particularly in diagnosing "mystery" infections and cases where conventional testing fails to provide a definitive result.
- The piece discusses the technical and logistical challenges that remain, such as distinguishing between true pathogens and the human microbiome, as well as the need for faster, more cost-effective implementation in hospital settings.